PDCD1 and neoplasm: Both IL-10 and ANGPT2 are contained in transcriptional signatures associated with resistance against anti-PD-1 antibodies in melanoma patients, indicating that they rapidly act on the immune regulatory mechanism and can promote immune escape and, ultimately, tumor growth [92].